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Abstract
Purpose We have previously demonstrated that dogs can be trained to distinguish the urine of patients with obstructive sleep
apnea (OSA) from that of healthy controls based on olfaction. Encouraged by these promising results, we wanted to investigate if
a detection dog could work as a screening tool for OSA. The objective of this study was to prospectively assess the dogs’ ability
to identify sleep apnea in patients with OSA suspicion.
Methods Urine samples were collected from 50 patients suspected of having OSA. The urine sample was classified as positive
for OSA when the patient had a respiratory event index of 5/h or more. The accuracy of two trained dogs in identifying OSAwas
tested in a prospective blinded setting.
Results Both of the dogs correctly detected approximately half of the positive and negative samples. There were no statistically
significant differences in the dogs’ ability to recognize more severe cases of OSA, as compared to milder cases.
Conclusion According to our study, dogs cannot be used to screen for OSA in clinical settings, most likely due to the heterogenic
nature of OSA.
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Introduction
Polysomnography (PSG) is the standard method for diagnos-
ing obstructive sleep apnea (OSA). However, there is an ur-
gent need to develop new approaches to diagnose and screen
for OSA due to its high prevalence and the relatively limited
access to PSG. Meanwhile, there exist substantial health care
and social costs of undiagnosed OSA [1]. An ideal screening
tool would be accurate, affordable, easy to use, and highly
accessible with no side effects to the patient [2].
Within this context, there may be a role for detection dogs.
Dogs possess excellent proficiency at detecting a wide range of
scents. Their olfactory sensitivity can be up to 100,000 times
better than that of humans. Dogs have been successfully trained
to detect different cancers [3–5] and infectious diseases [6, 7].
Medical detection dogs could represent an economical and
robust option in screening for OSA. We have previously dem-
onstrated that dogs can be trained to distinguish OSA urine from
healthy control samples based on olfaction [8]. Two of our three
dogs correctly detected two-thirds of OSA patient samples.
Our aim was to assess the dogs’ ability to identify




The dogs used in this study were a German Spitz Mittel (Dog
1; female, 4 years old) and a Labrador Retriever (Dog 2;
female, 4 years old). Both the dogs and trainers had previous
experience with olfactory-based detection, and they had
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Training
The initial training period was 1–2 months. The training was
based exclusively on operant conditioning with positive rein-
forcement. The correct response for the OSA sample was ei-
ther sitting in front of the sample or standing still and pointing
the nose at the sample for a minimum of 5 s. The correct
response for negative samples was to ignore the sample.
Patients and urine samples
Urine samples were collected from 50 patients who were re-
ferred to the Department of Otorhinolaryngology in Päijät-
Häme Central Hospital on suspicion of OSA. The patient
was suspected of having OSA if he/she presented with the
following symptoms: snoring and/or witnessed apneas and
daytime tiredness. All patients underwent a cardio-
respiratory sleep study. Urine samples were fractioned to
small microcentrifuge tubes and frozen at − 18 °C.
Sleep studies
All patients underwent a cardiorespiratory overnight sleep
study using a portable monitor (Nox T3, Nox Medical,
Iceland). Scoring was performed according to the AASM rec-
ommendations [9]. Sleep apnea was considered present when
the respiratory event index (REI) was ≥ 5/h. Otherwise, the
urine samples were considered negative for sleep apnea.
The test
The trainer was given a total of 100 samples, two samples
from each of the 50 patients. Dogs were presented two to four
samples daily, one sample at a time, and they had to identify
whether or not it was the target odour (OSA). All 50 patient
samples were tested once (1st try) and later, the second sam-
ples were tested (2nd try) so that each patient was tested twice.
The trainer was blinded, receiving a random number assigned
to the sample in order to avoid any possibility of signalling
between the trainer and the dog.
Statistics
The number of studied subjects was calculated according to
Casagrande and Pike [10]. According to these researchers, a
non-trained dog has a 50% chance of giving a right answer. If
we accept an α risk at 0.05 and a β risk at 0.05, we needed a
minimum of 42 subjects for our study. A chi-square test pro-
vided a comparison of the positive answers for dog 1 and dog
2. A p value < 0.05 was considered to be statistically signifi-
cant. Analyses were performed using IBM SPSS Statistics for
Windows (version 25.0).
Results
The 50 patients represented the following OSA categories: nor-
mal (REI < 5; n = 7; 14%), mild (5 ≤REI < 15; n = 16; 32%),
moderate (15 ≤REI <30; n = 10; 20%), and severe (REI ≥ 30;
n = 17; 34%). Table 1 illustrates these patient characteristics.
Dog 1 was able to give the right answer in 53% of cases [χ2
(3, N = 100) = 7.353, (p = 0.061)] and dog 2 in 52% of cases
[χ2 (3, N = 100) = 3982, (p = 0.263)]. Figure 1 indicates the
percentages (%) of right answers in terms of recognizing
OSA according to the severity classification categories.
Discussion
The chief finding of this study was that the two trained
dogs were unable to distinguish between urine samples
of patients with OSA from those of control subjects
who did not have OSA. This result was surprising since
in our previous study, the same dogs correctly detected
two-thirds of patients with OSA based on olfaction,
with impressive values of statistical significance
(p < 0.000003) [8].
Our findings were also disappointing in that the profi-
ciency of dogs in detecting a wide range of scents has
shown promise for medical screening purposes in other
settings. As examples, dogs’ specificity and sensitivity
Table 1 Patient characteristics in
OSA categories No OSA Mild OSA Moderate OSA Severe OSA
Number of patients 7 16 10 17
Women, n (%) 1 (14) 4 (25) 3 (30) 3 (18)
Smoker, n (%) 0 (0) 0 (0) 2 (20) 4 (24)
Age, mean (SD) 41 (14) 48 (12) 60 (8) 56 (14)
BMI, mean (SD) 28 (4) 28 (2) 31 (7) 33 (6)
REI, mean (SD) 2 (3) 9 (3) 24 (4) 51 (21)
No OSA =REI < 5, Mild = 5 ≤REI <15, Moderate = 15 ≤REI < 30, Severe = REI ≤ 30
REI respiratory event index, BMI body mass index, SD standard deviation, n number
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for detecting and discriminating cancer have been report-
ed to be above 90% [11–13]. Promising results have been
obtained for infectious diseases, such as Clostridium
difficile infections [6, 14] and urinary tract infections [7,
15]. Unfortunately, despite the encouraging results of our
first study, it seems that dogs cannot be used to screen
patients with OSA. Both of our dogs only detected about
half of the positive and negative samples.
There are several possible reasons for this failure.
First, OSA patients are known to have changes in their
urine metabolites [16, 17]. In our first study, we com-
pared samples from OSA patients with samples from
healthy individuals [8]. In this second study, urine sam-
ples came from individuals with suspected OSA. It is
possible that the dogs identified abnormal scents related
to OSA rather than scents specific to OSA.
Second, OSA is a heterogeneous disease with several phe-
notypes reported [18]. This heterogeneity also may influence
the metabolic processes and volatile compound profile of the
patient’s urine regardless of the severity of the disease. If so,
dogsmay recognize only a fraction of OSA patients belonging
to certain phenotypes. This hypothesis is supported by incon-
sistent findings in studies examining possible biomarkers for
OSA [16].
Finally, the testing procedure may have influenced the
results. In the first study, dogs were presented with four
samples, one of which was positive for OSA [8]. In this
study, one sample was presented at a time, and the dog
had to identify whether or not it was the target odour.
Instead of asking “Which one?”, the dog was challenged
by asking “Is it?”. Such identification tasks tend to be
more challenging than discrimination by comparison.
Contrary to our promising preliminary findings, the results
of this study indicate that dogs cannot be used to screen for
OSA in clinical settings. Detection dogs may not be a suitable
screening method for heterogeneous conditions, such as OSA.
Author contribution Study design: Klockars, Bachour, Koskinen A,
Bäck, Koskinen H
Sample collecting: Myller, Koskinen A, Klockars
Dog training and tests: Vaarno, Koskinen H
Data analysis: Bachour, Vaarno, Bäck
Manuscript drafting, revision and final approval: Vaarno, Koskinen A,
Bachour, Klockars, Bäck, Myller
Funding information Open access funding provided by University of
Helsinki including Helsinki University Central Hospital. We acknowl-
edge the financial support from the Finska Läkaresällskapet and the
Päivikki and Sakari Sohlberg Foundation.
Compliance with ethical standards
Conflict of interest The authors declare that they have no conflicts of
interest.
Ethics approval Informed consent was provided by all participants. The
study protocol was approved by the ethics committee of the Helsinki
University Hospital (Dno 168/13/03/00/16).
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing, adap-
tation, distribution and reproduction in any medium or format, as long as
you give appropriate credit to the original author(s) and the source, pro-
vide a link to the Creative Commons licence, and indicate if changes were
made. The images or other third party material in this article are included
in the article's Creative Commons licence, unless indicated otherwise in a
credit line to the material. If material is not included in the article's
Creative Commons licence and your intended use is not permitted by
statutory regulation or exceeds the permitted use, you will need to obtain
Fig. 1 Dogs’ percentage (%) of
right answers in OSA categories:
No OSA =REI < 5, mild = 5 ≤
REI <15, moderate = 15 ≤REI <
30, severe = REI ≤ 30. REI,
respiratory event index
1655Sleep Breath (2020) 24:1653–1656
permission directly from the copyright holder. To view a copy of this
licence, visit http://creativecommons.org/licenses/by/4.0/.
References
1. De Benedetto M, Garbarino S, Sanna A (2017) Obstructive sleep
apnea (OSA): healthcare and social costs. Med Lav 108:310–313
2. Pang KP, Terris DJ (2006) Screening for obstructive sleep apnea:
an evidence-based analysis. Am J Otolaryngol 27:112–118
3. Cornu JN, Cancel-Tassin G, Ondet V, Girardet C Cussenot O
(2011) olfactory detection of prostate cancer by dogs sniffing urine:
a step forward in early diagnosis. Eur Urol 2011 59:197–201
4. Ehmann R, Boedeker E, Friedrich U, Sagert J, Dippon J, Friedel G,
Walles T (2012) Canine scent detection in the diagnosis of lung
cancer: revisiting a puzzling phenomenon. Eur Respir 39:669–676
5. Pickel D, Manucy G, Walker D, Hall S, Walker J (2004) Evidence
for canine olfactory detection of melanoma. Appl Anim Behav Sci
89:107–116
6. Bomers MK, van Agtmael MA, Luik H, van Veen C,
Vandenbroucke-Grauls CM, Smulders YM (2012) Using a dog’s
superior olfactory sensitivity to identify clostridium difficile in
stools and patients: proof of principle study. BMJ. 345:e7396
7. Koskinen A, Koskinen H, Back L, Saxen H, Klockars T (2017) A
detection dog for paediatric urinary tract infection caused by
Escherichia coli. Infect Dis (Lond) 49:874–877
8. Koskinen A, Bachour A, Vaarno J, Koskinen H, Rantanen S, Bäck
L, Klockars T (2019) A detection dog for obstructive sleep apnea.
Sleep Breath 23:281–285
9. Berry RB, Brooks R, Gamaldo CE et al (2017) For the American
Academy of sleep medicine. The AASM manual for the scoring of
sleep and associated events: rules, terminology and technical
specifications. Version 2.4. American Academy of Sleep
Medicine, Darien, IL
10. Casagrande and Pike. In: LaPlanche A, Com-Nogue C and Flamant
R. Méthodes statistiques appliquées à la recherche clinique.
Flammarion Médecine; 1993. Chapter: Suppliment. Table 3
11. McCulloch M, Jezierski T, Broffman M, Hubbard A, Turner K,
Janecki T (2006) Diagnostic accuracy of canine scent detection in
early- and late-stage lung and breast cancers. Integr Cancer Ther
5(1):30–39
12. Guerrero-Flores H, Apresa-García T, Garay-Villar Ó et al (2017) A
non-invasive tool for detecting cervical cancer odor by trained scent
dogs. BMC Cancer 26;17(1):–79
13. Seo IS, Lee HG, Koo B, Koh CS, Park HY, Im C, Shin HC (2018)
Cross detection for odor of metabolic waste between breast and
colorectal cancer using canine olfaction. PLoS One 13;13(2):
e0192629
14. Taylor MT, McCready J, Broukhanski G, Kirpalaney S, Lutz H,
Powis J (2018) Using dog scent detection as a point-of-care tool to
identify toxigenic Clostridium difficile in stool. Open forum Infect
Dis 22;5(8):ofy179
15. Maurer M,McCulloch M, Willey AM, Hirsch W, Dewey D (2016)
Detection of bacteriuria by canine olfaction. Open Forum Infect Dis
9;3(2):ofw051
16. Xu CY, Li DJ, Wu CL, Lou HJ, Jiang HW, Ding GQ (2015) Serum
sLOX-1 levels are correlated with the presence and severity of
obstructive sleep apnea. Genet Test Mol Biomarkers 19:272–276
17. Canto Gde L, Pachêco-Pereira C, Aydinoz S, Major PW, Flores-
Mir C, Gozal D (2015) Biomarkers associated with obstructive
sleep apnea: a scoping review. Sleep Med Rev 23:28–45
18. Zinchuk A, Yaggi HK (2020) Phenotypic subtypes of OSA: a chal-
lenge and opportunity for precision. Chest 157(2):403–420
Publisher’s note Springer Nature remains neutral with regard to jurisdic-
tional claims in published maps and institutional affiliations.
1656 Sleep Breath (2020) 24:1653–1656
